Interação entre terapêuticas farmacológica e não farmacológica
317317
Bibliografia
1. GBD 2013 Mortality and Causes of Death Collaborators. Global,regional, and national age–sex
specific all‑cause and cause‑specific mortality for 240 causes of death, 1990–2013: a systematic
analysis forthe Global Burden of Disease Study 2013. The Lancet. 2015; 385,9963,117–171.
2. 2011 High level meeting on prevention and control of non‑communicable diseases. Political
declaration of the high‑level meeting of the general assembly on the prevention and control of
non‑communicable diseases. New York: United Nations General Assembly; 2011 (Document
A/66/L.1). Available from:
3. Yusuf S, Wood D, Ralston J, et al. The World Heart Federation’s vision for worldwide car-
diovascular disease prevention. Lancet. 2015; 386, 399–402.
4. Mampuya WM. Cardiac rehabilitation past, present and future: an overview. Cardiovasc
DiagnTher. 2012;2:38–49.
5. Anderson L, Taylor RS. Cardiac rehabilitation for people with heart disease: an overview of
Cochrane systematic reviews. Cochrane Database Syst Rev. 2014;12:CD011273.
6. Muller‑Riemenschneider F, Meinhard C, Damm K, et al. Effectiveness of nonpharmacological sec-
ondary prevention of coronary heart disease. Eur J Cardiovasc Prev Rehabil. 2010;17:688–700.
7. Piepoli MF, Corrà U, Benzer W, er al. Cardiac Rehabilitation Section of the European Associ-
ation of Cardiovascular Prevention and Rehabilitation. Secondary prevention through cardiac
rehabilitation: from knowledge to implementation. A position paper from the Cardiac Reha-
bilitation Section of the European Association of Cardiovascular Prevention and Rehabilita-
tion. Eur J Cardiovasc Prev Rehabil. 2010; 17:1‑17.
8. Arena R, Guazzi M, Lianov L, et al. Healthy life style interventions to combat non commu-
nicable disease‑a novel nonhierarchical connectivity model for key stakeholders: a policy
statement from the American Heart Association, European Society of Cardiology, European
Association for Cardiovascular Prevention and Rehabilitation, and American College of Pre-
ventive Medicine. Eur Heart J. 2015; 36:2097-2109.
9. Larsson SC, Akesson A, Wolk A. Healthy diet and lifestyle and risk of stroke in a prospective
cohort of women. Neurology. 2014;83:1699–1704.
10. Akesson A, Larsson SC, Discacciati A, et al. Low‑risk diet and lifestyle habits in the primary
prevention of myocardial infarction in men: a population‑based prospective cohort study. J
Am Colln Cardiol. 2014;64:1299–1306.
11. Lewinter C, Bland JM, Crouch S, et al. The effect of referral for cardiac rehabilitation on
survival following acute myocardial infarction: a comparison survival in two cohorts collected
in 1995 and 2003.Eur J Prev Cardiol. 2014;21:163‑71.
12. Turk‑Adawi K, Sarrafzadegan N, Grace SL. Global availability of cardiac rehabilitation Nat
Rev Cardiol. 2014;11:586‑96.
13. Bjarnason‑Wehrens B, McGee H, Zwisler AD et al. Cardiac Rehabilitation Section Euro-
pean Association of Cardiovascular Prevention and Rehabilitation. Cardiac rehabilitation in
Europe: results from the European Cardiac Rehabilitation Inventory Survey Eur J Cardiovasc
Prev Rehabil. 2010;17:410‑8.
14. Abreu A, Bettencourt N, Fontes P. Overview of cardiac rehabilitation in Portugal 2007‑2009.
Rev Port Cardiol. 2010;29:545‑58.
